Skip to main content

Portfolio Company Aptamer in the News

Portfolio Company Aptamer in the News

In December 2021 Seneca’s EIS and VCT funds invested £1.4m into Aptamer Group to support its £80m IPO. Twelve months later the Company has moved into bespoke, state of the art premises and further established itself in the research, diagnostics and therapeutics sectors globally. The founders spoke with a journalist from The Guardian to discuss the considerable progress made to date.

Click below to read the article

Aptamer: the York biotech working on precision cancer treatments | Biotechnology industry | The Guardian

Click below for Aptamer’s website

Home Page – Aptamer Group

Contact Us

Online form

If you have any questions about anything you’ve seen on our website then please get in touch. We are here to help. Normal office hours are weekdays 9.00am to 5.00pm. The office is not open on weekends or bank holidays.
  • Hidden
  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.